These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34519141)

  • 21. Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.
    Hua J; Zhang W; Cao HF; Du CL; Ma JY; Zuo YH; Zhang J
    BMJ Open; 2020 May; 10(5):e034804. PubMed ID: 32385061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.
    Suriyakul A; Saiphoklang N; Barjaktarevic I; Cooper CB
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can patients achieve sufficient peak inspiratory flow rate (PIFR) with Turbuhaler® during acute exacerbation of asthma?
    Mohd Rhazi NA; Muneswarao J; Abdul Aziz F; Ibrahim B; Kamalludin A; Soelar SA
    J Asthma; 2023 Aug; 60(8):1608-1612. PubMed ID: 36650693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data.
    Anderson M; Collison K; Drummond MB; Hamilton M; Jain R; Martin N; Mularski RA; Thomas M; Zhu CQ; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2021; 16():933-943. PubMed ID: 33883890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.
    Seheult JN; Costello S; Tee KC; Bholah T; Al Bannai H; Sulaiman I; Costello RW
    Springerplus; 2014; 3():496. PubMed ID: 25279290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Factors Affecting the Optimal and Non-optimal Peak Inspiratory Flow Rate in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease and Bronchial Asthma in India.
    Murugaiya S; Murugesan B; S P
    Cureus; 2024 Apr; 16(4):e58670. PubMed ID: 38774171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of chronic obstructive pulmonary disease patients with superoptimal peak inspiratory flow rate.
    Kim T; Moon JY; Park HY; Kim Y; Rhee CK; Lee CY; Park JH; Park YB; Russell R; Yoo KH; Ra SW
    Sci Rep; 2024 Jul; 14(1):15337. PubMed ID: 38961087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.
    Chapman KR; Fogarty CM; Peckitt C; Lassen C; Jadayel D; Dederichs J; Dalvi M; Kramer B
    Int J Chron Obstruct Pulmon Dis; 2011; 6():353-63. PubMed ID: 21760722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled salbutamol from aerolizer and diskus at different inhalation flows, inhalation volume and number of inhalations in both healthy subjects and COPD patients.
    Boshra MS; Almeldien AG; Eldin RS; Elberry AA; Abdelwahab NS; Salem MN; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2019; 45(3-4):84-91. PubMed ID: 31155973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wixela Inhub: Dosing Performance
    Cooper A; Parker J; Berry M; Wallace R; Ward J; Allan R
    J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):323-341. PubMed ID: 32429788
    [No Abstract]   [Full Text] [Related]  

  • 31. First-time handling of different inhalers by chronic obstructive lung disease patients.
    Harb HS; Laz NI; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625
    [No Abstract]   [Full Text] [Related]  

  • 32. Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease.
    Mahler DA
    Ann Am Thorac Soc; 2017 Jul; 14(7):1103-1107. PubMed ID: 28481631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults.
    Bronsky EA; Grossman J; Henis MJ; Gallo PP; Yegen U; Della Cioppa G; Kottakis J; Mehra S
    Curr Med Res Opin; 2004; 20(2):131-7. PubMed ID: 15006006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD.
    Mahler DA; Halpin DMG
    Chest; 2024 Feb; 165(2):323-332. PubMed ID: 37977266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD.
    Chen SY; Huang CK; Peng HC; Tsai HC; Huang SY; Yu CJ; Chien JY
    Front Pharmacol; 2021; 12():704316. PubMed ID: 34267665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
    Riley JH; Tabberer M; Richard N; Donald A; Church A; Harris SS
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1873-80. PubMed ID: 27578968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus™ dry powder inhaler.
    Seheult JN; O'Connell P; Tee KC; Bholah T; Al Bannai H; Sulaiman I; MacHale E; D'Arcy S; Holmes MS; Bergin D; Reeves E; Reilly RB; Crispino-O'Connell G; Ehrhardt C; Healy AM; Costello RW
    Pharm Res; 2014 Oct; 31(10):2735-47. PubMed ID: 24867420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.